United Therapeutics | UTHR - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Amarin USD 3K 5K 2024-12
Ardelyx USD 5.6M 160K 2026-03
Baxter International USD 78M 20M 2026-03
Bayer EUR 675M 87M 2025-12
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Gilead Sciences USD 247M 7M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
Halozyme Therapeutics USD 5.59M 80K 2026-06
Insmed USD 18.84M 1.24M 2026-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
J&J USD 43M 25M 2026-03
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Moderna USD 10.96B 527M 2026-06
Omeros USD 4.05M 5.16M 2024-09
Pfizer USD 667M 4M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Teva Pharmaceutical Industries USD 195M 21M 2026-06
United Therapeutics USD 2.9M 200K 2026-06
Vertex Pharmaceuticals USD 3.3M 0 2025-12